Overview

Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Status:
Terminated
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The current pilot study assesses the use of magnetic resonance imaging (MRI) to quantify hepatic steatosis. It will provide preliminary data regarding the use of omega-3 fatty acid supplementation (Lovaza) for the treatment of nonalcoholic steatohepatitis (NASH).
Phase:
Phase 2
Details
Lead Sponsor:
University of Illinois at Chicago